Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
33.67
-2.64 (-7.27%)
At close: Mar 27, 2026, 4:00 PM EDT
33.65
-0.02 (-0.06%)
After-hours: Mar 27, 2026, 7:32 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.53 billion as of March 27, 2026. Its market cap has increased by 8.13% in one year.
Market Cap
3.53B
Enterprise Value
2.55B
1-Year Change
8.13%
Ranking
Category
Stock Price
$33.67
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.53B, an increase of 525.16%. That is a compound annual growth rate of 26.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.53B | -20.19% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 4.10B |
| Ligand Pharmaceuticals | 4.06B |
| Viking Therapeutics | 3.96B |
| Centessa Pharmaceuticals | 3.95B |
| Spyre Therapeutics | 3.73B |
| Dianthus Therapeutics | 3.67B |
| ACADIA Pharmaceuticals | 3.66B |
| NewAmsterdam Pharma Company | 3.59B |